Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER

TORONTO, ON / ACCESSWIRE / March 4, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) ("Intellipharmaceutics" or the"Company"), a pharmaceutical company specializing in the research, development and...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news